Literature DB >> 4126702

Comparative study of the binding of coumarin anticoagulants and serum albumins.

S Garten, W D Wosilait.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 4126702     DOI: 10.1016/0006-2952(71)90294-2

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


× No keyword cloud information.
  11 in total

Review 1.  Protein binding of coumarin anticoagulants in disease states.

Authors:  K Bachmann; R Shapiro
Journal:  Clin Pharmacokinet       Date:  1977 Mar-Apr       Impact factor: 6.447

2.  Binding of certain acidic drugs to human albumin: theoretical and practical estimation of fundamental parameters.

Authors:  J P Tillement; R Zini; P d' Athis; G Vassent
Journal:  Eur J Clin Pharmacol       Date:  1974-07-26       Impact factor: 2.953

3.  Effect of phenylbutazone on the binding of vitamin K antagonists to albumin.

Authors:  J P Tillement; R Zini; C Mattei; E Singlas
Journal:  Eur J Clin Pharmacol       Date:  1973-06       Impact factor: 2.953

4.  An electrophoretic investigation of the binding of 3-14C coumarin to rat serum proteins.

Authors:  N B Piller; L H Schmitt
Journal:  Experientia       Date:  1977-08-15

5.  Inhibition of NAD(P)H:quinone oxidoreductase 1 activity and induction of p53 degradation by the natural phenolic compound curcumin.

Authors:  Peter Tsvetkov; Gad Asher; Veronica Reiss; Yosef Shaul; Leo Sachs; Joseph Lotem
Journal:  Proc Natl Acad Sci U S A       Date:  2005-04-04       Impact factor: 11.205

6.  Reaction mechanism of single subunit NADH-ubiquinone oxidoreductase (Ndi1) from Saccharomyces cerevisiae: evidence for a ternary complex mechanism.

Authors:  Yu Yang; Tetsuo Yamashita; Eiko Nakamaru-Ogiso; Takeshi Hashimoto; Masatoshi Murai; Junsuke Igarashi; Hideto Miyoshi; Nozomu Mori; Akemi Matsuno-Yagi; Takao Yagi; Hiroaki Kosaka
Journal:  J Biol Chem       Date:  2011-01-10       Impact factor: 5.157

7.  Tissue levels of (3(-14)C) coumarin in the rat: distribution and excretion.

Authors:  N B Piller
Journal:  Br J Exp Pathol       Date:  1977-02

8.  Interactions of some phenylindanedione anticoagulants with human serum albumin.

Authors:  J Paubel; P Niviere; M Payard; J C Rabadeux; C P Pinazzi
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1981       Impact factor: 2.441

9.  P53 hot-spot mutants are resistant to ubiquitin-independent degradation by increased binding to NAD(P)H:quinone oxidoreductase 1.

Authors:  Gad Asher; Joseph Lotem; Peter Tsvetkov; Veronica Reiss; Leo Sachs; Yosef Shaul
Journal:  Proc Natl Acad Sci U S A       Date:  2003-11-21       Impact factor: 11.205

10.  The effect of salicylate on the biliary excretion of 14C-bishydroxycoumarin in rat.

Authors:  H S Buttar; B B Coldwell; B H Thomas
Journal:  Br J Pharmacol       Date:  1973-06       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.